XML 31 R24.htm IDEA: XBRL DOCUMENT v3.24.3
Investments (Tables)
9 Months Ended
Sep. 30, 2024
Summary of Marketable Equity Securities Marketable equity securities as of September 30, 2024 and December 31, 2023, and activity for the nine months ended September 30, 2024 and year ended December 31, 2023, are as follows:

 

 

Cost

 

 

Cost of Shares Sold

 

 

Gross Unrealized Gain (Loss)

 

 

Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Marketable equity securities, September 30, 2024

 

$

17,860

 

 

$

-

 

 

$

984

 

 

$

18,844

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Marketable equity securities, December 31, 2023

 

$

743,906

 

 

$

(739,616

)

 

$

13,570

 

 

$

17,860

 

Schedule of Notes Receivable

 

September 30, 2024

 

 

December 31, 2023

 

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 Notes receivable from Seastar Medical Holding Corporation

$

-

 

 

$

1,440,498

 

 

$

2,254,668

 

 End of period

$

-

 

 

$

1,440,498

 

 

$

2,254,668

 

 

 

 

 

 

 

 

 

 

September 30, 2024

 

 

 

 

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 Beginning of year

$

1,440,498

 

 

 

 

 

$

3,807,749

 

 Repayment of Seastar Medical Holding Corporation notes receivable

 

(1,449,066

)

 

 

 

 

 

(1,661,727

)

 Accrued interest income

 

8,568

 

 

 

 

 

 

130,990

 

 Allowance for losses on Seastar Medical Holding Corporation notes receivable

 

-

 

 

 

 

 

 

(22,344

)

  End of period

$

-

 

 

 

 

 

$

2,254,668

 

Schedule of Investments for the Loan nvestments for the Loan consist of the following:

 

September 30, 2024

 

 

December 31, 2023

 

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 Current portion of notes receivable from Tech Infrastructure JV I LLC

$

711,840

 

 

$

-

 

 

$

-

 

 Notes receivable from Tech Infrastructure JV I LLC - net of current portion

 

2,269,863

 

 

 

 

 

 

 

 End of period

$

2,981,703

 

 

$

-

 

 

$

-

 

 

 

 

 

 

 

 

 

 

September 30, 2024

 

 

 

 

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 Beginning of year

$

-

 

 

 

 

 

$

-

 

 Borrowings

 

2,867,195

 

 

 

 

 

 

-

 

 Accrued interest income

 

114,508

 

 

 

 

 

 

-

 

  End of period

$

2,981,703

 

 

 

 

 

$

-

 

Information Regarding our Involvement in the VIE Information regarding our involvement in the VIE as of September 30, 2024 is as follows:

 

(in millions)

 

Financial Statement

 

 

Maximum

 

 

 

Carrying Amount

 

 

exposure to loss

 

Tech Infrastructure JV I LLC

 

$

 

3.0

 

 

$

 

3.0

 

Schedule of Long-term Investment - Equity Securities

Long-term investments in Seastar Medical private placement warrants consist of the following:

 

September 30, 2024

 

 

December 31, 2023

 

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 Seastar Medical Holding Corporation (formerly LMAO) warrants

$

8,944

 

 

$

156,992

 

 

$

72,815

 

 End of period

$

8,944

 

 

$

156,992

 

 

$

72,815

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30, 2024

 

 

 

 

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 Beginning of year

$

156,992

 

 

 

 

 

$

464,778

 

 Unrealized loss on equity securities

 

(148,048

)

 

 

 

 

 

(391,963

)

 End of period

$

8,944

 

 

 

 

 

$

72,815

 

Summary of Investment in Unconsolidated Affiliates

Long-term investments for the SeaStar Medical common stock consist of the following:

 

September 30, 2024

 

 

December 31, 2023

 

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 Seastar Medical Holding Corporation common stock

$

440,910

 

 

$

1,145,486

 

 

$

683,100

 

 End of period

$

440,910

 

 

$

1,145,486

 

 

$

683,100

 

 

 

 

 

 

 

 

 

 

 

September 30, 2024

 

 

 

 

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 Beginning of year

$

1,145,486

 

 

 

 

 

$

10,608,750

 

 Unrealized loss on equity investment

 

(704,576

)

 

 

 

 

 

(9,925,650

)

 End of period

$

440,910

 

 

 

 

 

$

683,100